《Update CRC April 2016 metastatic》培训课件.pptxVIP

;Survival of patients with mCRC in the last decades;;Case: Male 44y sigmoid Adenocarcinoma;Cae: male 44 years;Expect the impossible;mCRC: Liver limited disease;Randomized trials in patients with Liver limited disease;CELIM: R0 Resection as a surgical ?maintenance therapy“ in the continuum of care;Metastatic disease with no chance of later resection;;Oxaliplatin in adjuvant pretreated patients;BRAF mut;Can Targeting EGFR Overcome Resistance to BRAF + MEK Inhibitors in BRAFm CRC? ;Best Response With Confirmation br /Percent Change from Baseline at Maximum Reduction in Tumor Measurement